entinostat has been researched along with Inflammation in 13 studies
Inflammation: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Our findings indicate that single treatment with MS-275 and resveratrol can reduce stroke-mediated brain injury and inflammation observed 2 days after the pMCAO and put the rational to test repeated administration of the drugs." | 3.96 | Neuroprotective epi-drugs quench the inflammatory response and microglial/macrophage activation in a mouse model of permanent brain ischemia. ( Bellucci, A; Benarese, M; Mota, M; Parrella, E; Pizzi, M; Porrini, V; Rhein, S; Schwaninger, M, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 10 (76.92) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, F | 1 |
| Zwinderman, MRH | 1 |
| van Merkerk, R | 1 |
| Ettema, PE | 1 |
| Quax, WJ | 1 |
| Dekker, FJ | 1 |
| Wu, Y | 1 |
| Dou, J | 1 |
| Wan, X | 1 |
| Leng, Y | 1 |
| Liu, X | 1 |
| Chen, L | 2 |
| Shen, Q | 1 |
| Zhao, B | 1 |
| Meng, Q | 1 |
| Hou, J | 1 |
| Zierfuss, B | 1 |
| Weinhofer, I | 1 |
| Buda, A | 1 |
| Popitsch, N | 1 |
| Hess, L | 1 |
| Moos, V | 1 |
| Hametner, S | 1 |
| Kemp, S | 1 |
| Köhler, W | 1 |
| Forss-Petter, S | 1 |
| Seiser, C | 1 |
| Berger, J | 1 |
| Mota, M | 1 |
| Porrini, V | 1 |
| Parrella, E | 1 |
| Benarese, M | 1 |
| Bellucci, A | 1 |
| Rhein, S | 1 |
| Schwaninger, M | 1 |
| Pizzi, M | 1 |
| Zhang, H | 1 |
| Li, X | 1 |
| Zhang, Q | 1 |
| Yang, F | 3 |
| Chu, X | 1 |
| Zhang, D | 1 |
| Wang, L | 1 |
| Gong, Z | 1 |
| Nguyen, A | 1 |
| Ho, L | 1 |
| Workenhe, ST | 1 |
| Samson, J | 1 |
| Walsh, SR | 1 |
| Pol, J | 1 |
| Bramson, JL | 1 |
| Wan, Y | 1 |
| Ryu, Y | 1 |
| Kee, HJ | 1 |
| Sun, S | 1 |
| Seok, YM | 1 |
| Choi, SY | 1 |
| Kim, GR | 1 |
| Kee, SJ | 1 |
| Pflieger, M | 1 |
| Kurz, T | 1 |
| Kim, HS | 1 |
| Jeong, MH | 1 |
| Cantley, MD | 1 |
| Fairlie, DP | 1 |
| Bartold, PM | 1 |
| Marino, V | 1 |
| Gupta, PK | 1 |
| Haynes, DR | 1 |
| Yang, Y | 1 |
| Wang, Y | 1 |
| Li, CL | 1 |
| Wang, XL | 1 |
| Li, Z | 1 |
| Chen, J | 1 |
| Chiechio, S | 1 |
| Zammataro, M | 1 |
| Morales, ME | 1 |
| Busceti, CL | 1 |
| Drago, F | 1 |
| Gereau, RW | 1 |
| Copani, A | 1 |
| Nicoletti, F | 1 |
| Zhang, ZY | 3 |
| Zhang, Z | 1 |
| Schluesener, HJ | 3 |
1 trial available for entinostat and Inflammation
| Article | Year |
|---|---|
Role of histone deacetylase expression levels and activity in the inflammatory responses of patients with chronic hepatitis B.
Topics: Animals; Benzamides; Cytokines; Female; Gene Expression Regulation, Enzymologic; Hepatitis B, Chroni | 2017 |
12 other studies available for entinostat and Inflammation
| Article | Year |
|---|---|
Inhibitory selectivity among class I HDACs has a major impact on inflammatory gene expression in macrophages.
Topics: Anilides; Animals; Benzamides; Catalytic Domain; Gene Expression; Histone Deacetylase 1; Histone Dea | 2019 |
Histone Deacetylase Inhibitor MS-275 Alleviates Postoperative Cognitive Dysfunction in Rats by Inhibiting Hippocampal Neuroinflammation.
Topics: Animals; Benzamides; Cytokines; Hippocampus; Histone Deacetylase Inhibitors; Histone Deacetylases; H | 2019 |
Targeting foam cell formation in inflammatory brain diseases by the histone modifier MS-275.
Topics: Acute Disease; Adrenoleukodystrophy; Adult; Autopsy; Benzamides; Foam Cells; Gene Expression Profili | 2020 |
Neuroprotective epi-drugs quench the inflammatory response and microglial/macrophage activation in a mouse model of permanent brain ischemia.
Topics: Animals; Antioxidants; Benzamides; Disease Models, Animal; Histone Deacetylase Inhibitors; Infarctio | 2020 |
HDACi Delivery Reprograms Tumor-Infiltrating Myeloid Cells to Eliminate Antigen-Loss Variants.
Topics: Animals; Antigens, Neoplasm; Antineoplastic Agents; Benzamides; CD8-Positive T-Lymphocytes; Cell Pol | 2018 |
Class I histone deacetylase inhibitor MS-275 attenuates vasoconstriction and inflammation in angiotensin II-induced hypertension.
Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Aorta; Benzamides; Blood Pressure; Ce | 2019 |
Inhibiting histone deacetylase 1 suppresses both inflammation and bone loss in arthritis.
Topics: Animals; Arthritis, Experimental; Benzamides; Bone Resorption; Cells, Cultured; Chemokines; Cytokine | 2015 |
Selective class I histone deacetylase inhibitors suppress persistent spontaneous nociception and thermal hypersensitivity in a rat model of bee venom-induced inflammatory pain.
Topics: Animals; Bee Venoms; Benzamides; Epigenesis, Genetic; Histone Deacetylase 1; Histone Deacetylase 2; | 2015 |
Epigenetic modulation of mGlu2 receptors by histone deacetylase inhibitors in the treatment of inflammatory pain.
Topics: Amino Acids; Animals; Benzamides; Bridged Bicyclo Compounds, Heterocyclic; Enzyme Inhibitors; Epigen | 2009 |
MS-275, an histone deacetylase inhibitor, reduces the inflammatory reaction in rat experimental autoimmune neuritis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzamides; Cytokines; Demyelinating Diseases; Dru | 2010 |
HDAC inhibitor MS-275 attenuates the inflammatory reaction in rat experimental autoimmune prostatitis.
Topics: Animals; Autoimmune Diseases; Benzamides; Disease Models, Animal; Histone Deacetylase Inhibitors; Im | 2012 |
Oral administration of histone deacetylase inhibitor MS-275 ameliorates neuroinflammation and cerebral amyloidosis and improves behavior in a mouse model.
Topics: Administration, Oral; Alzheimer Disease; Amyloidosis; Animals; Behavior, Animal; Benzamides; Brain; | 2013 |